Baird Medical Investment Holdings Limited (BDMD)
$0.75-2.60%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $31M
- Beta
- -1.10
- P/E (TTM)
- -1.42
- Short % float
- 0.18%
- Days to cover
- 1.0
- SI change
- +5.6%
- 1W
- +1.35%
- 1M
- -31.82%
- vs SPY 1W
- +0.93%
- vs SPY 1M
- -33.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 42
- VALUE
- 23
- GROWTH
- 40
- GARP
- 87
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-29.0%
REV YoY-
ROE-48.3%
EPS YoY-
ROA-21.6%
GROSS86
OP-59
NET-65
[VALUATION]
P/E TTM-1.42
P/E FWD6.31
SECTOR PE20.54
INDUSTRY PE22.84
P/B0.92
P/FCF-
EV/EBITDA-3.60
EV/EBIT-
PEG0.08
FCF YIELD-
RISK
INT COV-
D/E40.90
ALTMAN Z-
CURR RATIO1.29
ND/EBITDA-
BETA-1.10
Company news
FAQ
- What is LOPJLB’s current signal on BDMD?
- LOPJLB’s latest quantitative signal on Baird Medical Investment Holdings Limited (BDMD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BDMD in?
- Baird Medical Investment Holdings Limited (BDMD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Baird Medical Investment Holdings Limited (BDMD) do?
- Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions.…